MP
Matthew Potter
OtherActiveVice President at TCV
New York, United StatesFounded 2013
52
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Matthew Potter.
Investment Thesis & Strategy
As a Vice President at TCV, Matthew Potter invests in various stages of growth-stage companies, with a focus on the New York City market. TCV typically seeks to invest in leading technology companies.
Portfolio Companies
Selected investments from their portfolio of 52 companies
N
NeuroVista
Other · , 0
L
Labcyte
Other · , 0
S
Senseonics
Other · , 0
N
NeurAxon
Other · , 0
B
Breathe Technologies
Other · , 0
C
Cardeas Pharma
Other · , 0
R
Revance Therapeutics
Other · , 0
V
VytronUS
Other · , 0
N
NovaSys
Other · , 0
F
ForSight Labs
Other · , 0
R
Reliant Technologies
Other · , 0
T
Tandem Diabetes Care
Other · , 0
Frequently Asked Questions
Matthew Potter invests across multiple stages. Sign up to view detailed stage data.